Work

Adding bevacizumab to single-agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost-effectiveness analysis of the AURELIA trial

Year: 2016

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2016.04.116

Authors: W.Z. Wysham, E.M. Schaffer, T.M. Coles, D.R. Roque, S.B. Wheeler, K.H. Kim

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4255226540

FWCI:

Cites:

Cited by:

Related to: 10